Table: Kobayashi Pharmaceutical -Q1 group results
Apr 25 (Reuters)-
Kobayashi Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2018 Mar 31, 2017 Dec 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 33.72 30.75 163.00
(+9.6 pct) (+4.0 pct)
Operating 5.57 4.96 23.70
(+12.3 pct) (+3.4 pct)
Recurring 5.42 4.85 24.80
(+11.6 pct) (+2.5 pct)
Net 3.82 3.46 17.00
(+10.6 pct) (+7.2 pct)
EPS 48.39 yen 43.84 yen 215.33 yen
EPS Diluted 48.34 yen 43.81 yen
Ann Div 58.00 yen 60.00 yen
-Q2 div 28.00 yen 30.00 yen
-Q4 div 30.00 yen 30.00 yen
NOTE - Kobayashi Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows